novel transcript, antisense to NT5DC3 (ENSG00000257754)

ENSG00000257754 refers to a novel antisense transcript to the NT5DC3 gene, but there is no evidence to suggest this entry defines a canonical protein, receptor, enzyme, or established therapeutic target. NT5DC3 itself encodes 5'-nucleotidase domain containing 3 and has biological roles including hydrolase activity and involvement in mitochondrial function, and it is associated with hereditary spastic paraplegia[1][2][3]. The antisense transcript likely serves regulatory or non-coding RNA functions and does not represent a recognized drug target or well-characterized molecule. No standard abbreviation, aliases, drug interactions, mechanisms, or disease associations are established for this transcript. Summary: - This entity is not a validated protein or drug target but a genomic annotation of a non-coding RNA transcript on the antisense strand of the NT5DC3 locus. - "NT5DC3" (5'-Nucleotidase domain containing 3) is the canonical gene and may be a therapeutic target, but "novel transcript, antisense to NT5DC3" is not. - There is nothing to suggest it is a receptor, enzyme, or target of clinical/pharmacological interest.